
   
   
      
         
            AIDS_NNP Is_VBZ n't_RB Over_IN

            Ever_RB since_IN it_PRP was_VBD announced_VBN
at_IN a_DT 1984_CD press_NN conference_NN that_IN HIV_NNP was_VBD the_DT cause_NN of_IN the_DT immune-system_NN mayhem_NN
known_VBN as_IN AIDS_NNP ,_, seers_NNS have_VBP periodically_RB predicted_VBN that_IN the_DT end_NN of_IN the_DT epidemic_NN
was_VBD near_IN ._. But_CC the_DT trumpets_VBZ have_VBP grown_VBN louder_RBR in_IN recent_JJ weeks_NNS ,_, as_IN the_DT success_NN of_IN
the_DT "_'' triple-combo_JJ therapy_NN "_'' of_IN protease_NN inhibitors_NNS ,_, AZT_NNP ,_, and_CC 3_CD TC_NNP has_VBZ been_VBN
recorded_VBN ._.

            
Popularizing_NNP these_DT findings_NNS earlier_RBR this_DT month_NN were_VBD two_CD HIV-positive_NNP
journalists_NNS ._. Writing_VBG on_IN the_DT front_JJ page_NN of_IN the_DT Nov_NNP ._. 8_CD Wall_NNP Street_NNP
Journal_NNP ,_, editor_NN David_NNP Sanford_NNP described_VBD how_WRB new_JJ anti-_NN HIV_NNP treatments_NNS had_VBD
rescued_VBD him_PRP from_IN death_NN 's_POS door_NN (_( "_'' Last_JJ Year_NN ,_, This_DT Editor_NNP Wrote_VBD His_PRP$ Own_JJ
Obituary_NNP "_'' )_) ._. Two_CD days_NNS later_RB ,_, Andrew_NNP Sullivan_NNP published_VBD his_PRP$ 8_CD ,_, 400_CD -_: word_NN literary_JJ
tour_NN de_IN force_NN ,_, "_'' When_WRB AIDS_NNP Ends_NNPS ,_, "_'' in_IN the_DT New_NNP York_NNP Times_NNP Magazine_NNP ._.
According_VBG to_TO Sullivan_NNP ,_, the_DT success_NN of_IN new_JJ anti-_NN HIV_NNP drugs_NNS has_VBZ triggered_VBN the_DT
"_'' twilight_NN of_IN an_DT epidemic_NN "_'' -_: -_: for_IN those_DT who_WP can_MD afford_VB the_DT $_$ 10_CD ,_, 000_CD -_: plus-a-year_JJ
regimens_NNS ._. A_DT diagnosis_NN of_IN HIV_NNP infection_NN ,_, he_PRP contends_VBZ ,_, "_'' no_RB longer_RB signifies_NNS
death_NN ,_, "_'' but_CC "_'' merely_RB signifies_NNS illness_NN ._. "_''

            Study_NNP after_IN study_NN has_VBZ shown_VBN that_IN in_IN many_JJ patients_NNS ,_, the_DT
triple-combo_JJ therapy_NN so_RB dramatically_RB reduces_VBZ the_DT amount_NN of_IN HIV_NNP found_VBD in_IN
blood--their_JJ viral_JJ loads--that_JJ the_DT most_RBS sensitive_JJ tests_NNS available_JJ cannot_NN detect_VBP
the_DT virus_NN ._. An_DT "_'' undetectable_JJ "_'' viral_JJ load_NN is_VBZ not_RB the_DT same_JJ as_IN being_VBG free_JJ of_IN HIV_NNP ,_,
but_CC many_JJ researchers_NNS believe_VBP that_IN less_JJR virus_NN equals_VBZ less_JJR damage_NN to_TO the_DT immune_JJ
system_NN ._. For_IN certain_JJ ,_, the_DT new_JJ treatments_NNS are_VBP having_VBG a_DT visible_JJ effect_NN on_IN the_DT
health_NN of_IN the_DT HIV-infected_NNP ,_, as_IN David_NNP Sanford_NNP 's_POS Lazarus-like_NNP turnaround_NN attests_VBZ ._.
Some_DT AIDS_NNP researchers_NNS ,_, encouraged_VBN by_IN the_DT early_JJ results_NNS with_IN triple-combo_JJ
therapy_NN ,_, are_VBP investigating_VBG whether_IN it_PRP 's_VBZ possible_JJ to_TO completely_RB clear--_JJ "_'' or_CC
eradicate_VB "_'' -_: -_: HIV_NNP from_IN the_DT bodies_NNS of_IN people_NNS who_WP begin_VBP treatment_NN shortly_RB after_IN
becoming_VBG infected_JJ ._.

            Given_VBN
their_PRP$ personal_JJ struggles_NNS against_IN AIDS_NNP ,_, Sanford_NNP and_CC Sullivan_NNP 's_POS exhilaration_NN at_IN
this_DT news_NN is_VBZ understandable_JJ ._. But_CC their_PRP$ celebrations_NNS are_VBP premature--the_JJ defeat_NN
of_IN AIDS_NNP is_VBZ completely_RB overstated_VBN ._. HIV_NNP still_RB poses_VBZ a_DT sobering_JJ list_NN of_IN scientific_JJ
unknowns_NNS ,_, which_WDT the_DT optimists_NNS dismiss_VBP far_RB too_RB quickly_RB ._. With_IN all_DT best_JJS wishes_VBZ to_TO
Sanford_NNP ,_, it_PRP 's_VBZ foolhardy_JJ for_IN him_PRP to_TO say_VB ,_, "_'' I_PRP 've_VBP survived_VBN this_DT scourge_NN ,_, "_'' and_CC that_IN
because_IN of_IN the_DT advent_NN of_IN protease_NN inhibitors_NNS ,_, "_'' I_PRP am_VBP probably_RB more_RBR likely_JJ to_TO be_VB
hit_VBN by_IN a_DT truck_NN than_IN to_TO die_NN of_IN AIDS_NNP ._. "_'' Sullivan_NNP 's_POS more_RBR daring_JJ pronouncement_NN that_IN
"_'' this_DT ordeal_NN as_IN a_DT whole_NN may_MD be_VB over_IN "_'' is_VBZ likely_JJ to_TO mislead_NN sick_JJ people_NNS in_IN need_NN
of_IN hope_VBP ._. And_CC the_DT argument_NN that_IN AIDS_NNP is_VBZ conquered_JJ may_MD also_RB lend_VB a_DT sharper_JJR ax_NN to_TO
the_DT legislators_NNS who_WP perennially_RB argue_VBP to_TO cut_VB the_DT AIDS-research_JJ budget_NN ._.

            
There_EX are_VBP plenty_RB of_IN reasons_NNS to_TO be_VB skeptical_JJ
about_IN the_DT power_NN of_IN these_DT new_JJ treatments_NNS ._. There_EX are_VBP scant_JJ data_NNS to_TO explain_VB how_WRB
long_JJ these_DT new_JJ treatments_NNS will_MD prevent_VB disease_NN and_CC extend_VB life--no_JJ formal_JJ
studies_NNS have_VBP been_VBN completed_VBN that_WDT compare_VBP hundreds_NNS of_IN treated_VBN people_NNS with_IN
hundreds_NNS of_IN untreated_JJ people_NNS ._. Another_DT downside_NN to_TO the_DT drugs_NNS is_VBZ that_IN they_PRP often_RB
make_VBP people_NNS feel_VBP nauseated_JJ and_CC can_MD have_VB serious_JJ toxicities_NNS ._. In_IN some_DT people_NNS ,_,
these_DT drugs_NNS only_RB work_VBP for_IN a_DT short_JJ time_NN ;_: in_IN others_NNS ,_, the_DT drugs_NNS make_VBP HIV_NNP
undetectable_JJ ,_, but_CC their_PRP$ immune_JJ systems_NNS are_VBP too_RB damaged_VBN to_TO rebound_VB ._. HIV_NNP remains_VBZ
a_DT stealthy_NN foe_NN :_: It_PRP can_MD take_VB refuge_NN in_IN body_NN tissues_NNS (_( as_IN opposed_VBN to_TO blood_NN )_) ,_, where_WRB
the_DT drugs_NNS have_VBP a_DT harder_RBR time_NN reaching_NN ._. And_CC the_DT virus_NN routinely_RB mutates_NNS into_IN
strains_NNS that_WDT are_VBP resistant_JJ to_TO every_DT drug_NN that_WDT has_VBZ proven_VBN effective_JJ against_IN
it_PRP ._.

            Sullivan_NNP 's_POS article_NN notes_NNS
these_DT depressing_JJ findings_NNS alongside_IN his_PRP$ good_JJ news_NN ._. But_CC there_EX is_VBZ plenty_NN of_IN bad_JJ
news_NN that_IN he_PRP does_VBZ n't_RB report_VB ._. The_DT lymph_NN nodes_NNS (_( and_CC other_JJ sites_NNS in_IN the_DT body_NN )_) can_MD
be_VB packed_VBN with_IN HIV_NNP even_RB when_WRB the_DT virus_NN is_VBZ undetectable_JJ in_IN the_DT blood_NN ._. At_IN last_JJ
summer_NN 's_POS international_JJ AIDS_NNP conference_NN ,_, researchers_NNS described_VBD a_DT patient_NN who_WP had_VBD
been_VBN treated_VBN for_IN 78_CD weeks_NNS with_IN a_DT combination_NN of_IN drugs_NNS ,_, and_CC in_IN whom_WP they_PRP could_MD
detect_VB no_DT virus_NN ._. When_WRB he_PRP stopped_VBD taking_VBG his_PRP$ medicine_NN ,_, high_JJ levels_NNS of_IN HIV_NNP
returned_VBD in_IN a_DT week_NN ._. An_DT AIDS_NNP researcher_NN told_VBD me_PRP last_JJ week_NN of_IN four_CD patients_NNS who_WP
recently_RB died_VBD from_IN AIDS_NNP ,_, even_RB though_IN their_PRP$ viral_JJ loads_NNS had_VBD become_VBN undetectable_JJ
with_IN the_DT new_JJ drug_NN treatments_NNS ._. Just_RB because_IN you_PRP drive_VBP a_DT viral_JJ load_NN to_TO the_DT point_NN
where_WRB it_PRP ca_MD n't_RB be_VB detected_VBN does_VBZ n't_RB mean_VB the_DT immune_JJ system_NN returns_NNS to_TO normal_JJ ._.
There_EX are_VBP also_RB the_DT practical_JJ obstacles_NNS to_TO AIDS_NNP optimism_NN ._. Taking_VBG two_CD dozen_NN or_CC
more_JJR pills_NNS a_DT day_NN ,_, on_IN a_DT schedule_NN ,_, is_VBZ a_DT daunting_JJ task_NN to_TO carry_VB out_IN for_IN years_NNS on_IN
end_NN ._. Missed_NNP pills_NNS lower_VB the_DT potency_NN of_IN the_DT treatment_NN ,_, opening_VBG the_DT way_NN to_TO
drug-resistant_JJ HIV_NNP mutants_NNS ._.

            HIV_NNP has_VBZ a_DT
long_JJ history_NN of_IN laughing_VBG last_JJ ._.

            I_PRP 'm_VBP not_RB a_DT defeatist_NN ,_, mind_NN you_PRP ._. Measured_VBN optimism_NN is_VBZ
warranted_VBN ._. Although_IN the_DT vast_JJ majority_NN of_IN HIV-infected_NNP people_NNS in_IN the_DT world_NN
cannot_NN afford_VBP these_DT new_JJ treatments_NNS ,_, for_IN those_DT who_WP can_MD ,_, the_DT drugs_NNS will_MD possibly_RB
stave_VB off_IN disease_NN and_CC death_NN ._. But_CC ,_, because_IN no_DT one_CD knows_VBZ whether_IN these_DT new_JJ leases_NNS
on_IN life_NN should_MD be_VB measured_VBN in_IN weeks_NNS ,_, months_NNS ,_, years_NNS ,_, or_CC decades_NNS ,_, balancing_VBG
optimism_NN and_CC pessimism_NN requires_VBZ a_DT delicate_JJ touch_NN ._.

            Consider_VB
the_DT history_NN of_IN the_DT drug_NN AZT_NNP ,_, which_WDT has_VBZ seesawed_JJ in_IN the_DT public_JJ perception_NN from_IN
panacea_NN to_TO poison_NN and_CC back_RB again_RB ._. When_WRB first_RB approved_VBN by_IN the_DT FDA_NNP in_IN 1987_CD ,_, AZT_NNP
was_VBD hailed_VBN as_IN a_DT godsend_NN ._. Then_RB it_PRP was_VBD denounced_VBN as_IN ineffective_JJ by_IN activists_NNS ,_,
after_IN larger_JJR studies_NNS showed_VBD that_IN ,_, when_WRB taken_VBN alone_RB ,_, the_DT drug_NN offered_VBD little_JJ
except_IN to_TO the_DT sickest_NN people_NNS ._. Worse_JJR yet_RB ,_, many_JJ HIV-infected_NNP people_NNS viewed_VBD the_DT
drug_NN as_IN a_DT worthless_JJ poison_NN being_VBG hawked_JJ by_IN researchers_NNS who_WP were_VBD on_IN the_DT take_NN
from_IN a_DT greedy_JJ pharmaceutical_JJ company_NN ._. Today_NN ,_, AZT_NNP is_VBZ seen_VBN as_IN a_DT mediocre_JJ but_CC
useful_JJ medicine_NN :_: It_PRP has_VBZ a_DT place_NN in_IN the_DT triple-combo_JJ therapy_NN ,_, and_CC it_PRP can_MD prevent_VB
the_DT transmission_NN of_IN HIV_NNP from_IN infected_JJ mothers_NNS to_TO their_PRP$ babies_NNS two-thirds_NNS of_IN the_DT
time_NN ._.

            
From_IN here_RB ,_, many_JJ HIV_NNP researchers_NNS are_VBP putting_VBG
their_PRP$ hopes_NNS on_IN combining_VBG drug_NN treatments_NNS with_IN strategies_NNS that_WDT boost_VBP the_DT immune_JJ
system_NN ._. For_IN just_RB one_CD example_NN ,_, triple-combo_JJ therapy_NN is_VBZ now_RB being_VBG tested_VBN in_IN
conjunction_NN with_IN interleukin-_NN 2_CD ,_, an_DT immune-system_NN messenger_NN that_IN theoretically_RB
can_MD help_VB rev_NN up_RP the_DT natural_JJ machinery_NN that_WDT clears_VBZ the_DT virus_NN from_IN the_DT body_NN ._.

            But_CC the_DT real_JJ hope_NN for_IN ending_VBG
the_DT AIDS_NNP epidemic_NN is_VBZ not_RB expensive_JJ drug_NN therapies_NNS ._. Never_RB in_IN the_DT annals_NN of_IN
medicine_NN has_VBZ a_DT viral_JJ plague_VB been_VBN stopped_VBN by_IN any_DT therapy_NN ._. Viral_NNP plagues_NNS such_JJ as_IN
smallpox_NN ,_, polio_NN ,_, measles_NNS ,_, hepatitis_NNP B_NNP ,_, rabies_NNS ,_, and_CC other_JJ once-terrifying_JJ
scourges_NNS have_VBP only_RB been_VBN beaten_VBN back_RB by_IN vaccines_NNS ._. It_PRP is_VBZ most_RBS perplexing_JJ then_RB ,_,
that_IN Sullivan_NNP ,_, who_WP is_VBZ writing_VBG about_IN the_DT end_NN of_IN an_DT epidemic_NN ,_, after_IN all_DT ,_, never_RB
mentions_VBZ the_DT word_NN "_'' vaccine_NN "_'' in_IN his_PRP$ article_NN ._. That_DT 's_VBZ because_IN his_PRP$ true_JJ focus_NN is_VBZ n't_RB
the_DT end_NN of_IN the_DT epidemic_NN ,_, but_CC lengthening_VBG the_DT lives_NNS of_IN the_DT already_RB infected_JJ ._.

            The_DT search_NN for_IN an_DT AIDS_NNP
vaccine_NN currently_RB needs_VBZ serious_JJ help_NN ,_, with_IN the_DT U_NNP ._. S_NNP ._. government_NN ,_, the_DT biggest_JJS
investor_NN in_IN the_DT effort_NN ,_, spending_VBG less_JJR than_IN 10_CD percent_NN of_IN its_PRP$ AIDS-research_JJ
budget_NN on_IN the_DT problem_NN ._. And_CC ,_, primarily_RB because_IN of_IN the_DT daunting_JJ scientific_JJ
obstacles_NNS ,_, woefully_RB few_JJ companies_NNS have_VBP an_DT aggressive_JJ AIDS-vaccine_NNP program_NN ._.

            So_RB roll_NN
up_RP the_DT red_JJ carpet_NN ,_, send_VBP the_DT band_NN home_NN ,_, and_CC recork_NN the_DT champagne_NN ._. These_DT rumors_NNS
of_IN AIDS_NNP survival_NN are_VBP greatly_RB exaggerated_JJ ._.

         
      
   
